| Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-28 |
| 2022 | $-41 |
| 2021 | $-49 |
| 2020 | $-32 |
| 2019 | $-27 |
| 2018 | $-30 |
| 2017 | $-14 |
| 2016 | $-22 |
| 2015 | $-13 |
| 2014 | $-7 |
| 2013 | $1 |
| Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-3 |
| 2024-06-30 | $-4 |
| 2024-03-31 | $-5 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $3 |
| 2023-03-31 | $-15 |
| 2022-12-31 | $-11 |
| 2022-09-30 | $-11 |
| 2022-06-30 | $-12 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-10 |
| 2021-09-30 | $-18 |
| 2021-06-30 | $-16 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-12 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-4 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-3 |
| 2019-06-30 | $-12 |
| 2019-03-31 | $-11 |
| 2018-12-31 | $-12 |
| 2018-09-30 | $-8 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $7 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-8 |
| 2016-12-31 | $-6 |
| 2016-09-30 | $-6 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NPK (NPKI) | United States | $0.626B | 27.85 |
| Performant Healthcare (PHLT) | United States | $0.245B | 0.00 |
| FTAC Emerald Acquisition (FLDD) | United States | $0.158B | 0.00 |
| Swiftmerge Acquisition (ANNA) | United States | $0.042B | 0.00 |
| Insight Acquisition (AMOD) | United States | $0.023B | 0.00 |
| Hanryu Holdings (GITS) | South Korea | $0.017B | 0.00 |
| Pieris Pharmaceuticals (PVLA) | United States | $0.016B | 0.00 |
| LQR House (YHC) | United States | $0.011B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.009B | 0.00 |
| Lion Electric (LEVGQ) | Canada | $0.000B | 0.00 |